ZBH

ZBH

USD

Zimmer Biomet Holdings Inc. Common Stock

$103.180+3.170 (3.170%)

リアルタイム価格

Healthcare
医療機器
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$100.010

高値

$103.690

安値

$99.455

出来高

9.20M

企業ファンダメンタルズ

時価総額

20.4B

業種

医療機器

United States

取引統計

平均出来高

1.41M

取引所

NYQ

通貨

USD

52週レンジ

安値 $89.22現在値 $103.180高値 $114.72

関連ニュース

PR Newswire

Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has ...

もっと見る
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Analyst Upgrades

Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings with a Hold and maintains $101 price target.

もっと見る
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target
PR Newswire

Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting bold innovations across ...

もっと見る
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Analyst Upgrades

BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122

BTIG analyst Ryan Zimmerman maintains Zimmer Biomet Holdings with a Buy and raises the price target from $118 to $122.

もっと見る
BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122
PR Newswire

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the...

もっと見る
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
Analyst Upgrades

Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $104

Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings with a In-Line and lowers the price target from $106 to $104.

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。